Narcotics Enforcement Division
3375 Koapaka Street, Suite D-100
Honolulu, Hawaii 96819
Phone: 837-8470
Fax: 837-8474
E-mail: hawaiicsreg@hawaii.gov
FORM REQUIRED FOR PRACTITIONER, APRN, AND PA RENEWALS: 2025 Prescriber Education Attestation Form
- Hawaii Controlled Substance Registration
- HI-PDMP -Hawaii-Prescription Drug Monitoring Program AwaRxE
- Hawaii Controlled Substance Laws and Administrative Rules
- In the News, Community Programs & Events
- Controlled Substance Schedules
- Online Application for Practitioners, APRNs, PAs, and Pharmacies
- Mail-In Application Form for Practitioners, APRNs, and PAs
- Mail-In Controlled Substance Application for Business Organizations (i.e. pharmacy, LTC, etc.)
- Fees and Instructions for Practitioners, APRNs, and PAs
- Instructions for Fee Exempt Registration – New and Renewal Requirements Effective 04-01-2022
- Attestation to Hawaii Law and Requirements Form
- Wet Signature Exemplar form
- Prescriber Education Attestation form
- Physician’s Assistant – Supervising Physician Addendum Form
- Pre-Inspection form – To administer own stock and dispense controlled substances
| PRINT YOUR CERTIFICATE ONLINE |
| Effective January 1, 2024, you must retrieve and print your controlled substance certificate via your NED Self-Service Portal |
| Log in using your existing eHawaii.gov account. Obtain your certificate through the “My Registration” tab. |
- HRS 329 (Title 19: Health HRS 329 Uniform Controlled Substances Act)
- HRS 329 D (Title 19: Health HRS 329D Medical Marijuana Dispensary System)
- HRS 712 (Title 37: Hawaii Penal Code HRS 712 Offenses Against Public Health and Morals) Note: Statutes pertaining to OFFENSES RELATED TO DRUGS AND INTOXICATING COMPOUNDS begin with HRS 712-1240
- Title 23 Chapter 200 Administrative Rule: Regulation of Controlled Substances
- Title 23 Chapter 201 Administrative Rule: Regulated Chemicals for the Manufacture of Controlled Substances
- Temporary Scheduling of New Controlled Substances 2024
- Notice of Federal Scheduling 2022 Various Substances
- notice of emergency Scheduling Action MDMB.4en.pinaca notice
Federal Scheduling Actions 2018-2020
- notice of Federal Scheduling Action brexanolone 2020
- notice of emergency Scheduling Action etizolam and flualprazolam
- notice of Federal Scheduling Action new controlled substances October 2021
- notice of Federal Scheduling Action new fentanyls october 12 2020
- notice of Federal Scheduling Action epidiolex August 21 2020
- notice of Federal Scheduling Action norfentanyl April 17 2020
- notice of Federal Scheduling Action solriamfetol january 7 2020
- Act 256 2019/SB536 Prescription requirements related to schedule II drugs
- federal scheduling action of fentanyl analogs August 2019
- Act 190 became law 07-01-2018 (relating to scheduling actions of substituted cathinones,, cumyl-4-cn-binaca and dronabinol) Note: Archives contain previous emergency scheduling actions of these chemicals
- Federal Scheduling Action Epidiolex October 2018
2018 and 2019 NEW & CHANGES TO THE LAW
- Act 95 2019/SB 1263 Amends the Uniform Controlled Substance Act by updating Schedule V and amending requirements for electronic prescriptions, for consistency with federal law.
- Act 230 2019/SB1486 Amends Electronic Prescription Accountability system (HI-PDMP)
- Act 251 2019/HB665 Exceptions to query of Electronic Prescription Accountability System (HI-PDMP)
- Act 256 2019/SB536 Prescription requirements related to schedule II drugs
- Act 95 2019/SB 1263 Addition of FDA approved CBD drugs to Schedule V
- Act 066/Senate Bill 505(2017) Effective 07-01-18. Requirement for policy or and written agreements to engage in an informed consent process between the prescribing provider and qualifying opioid therapy patient. Related Resource: Hawaii Department of Health, Patient Informed Consent Form also the Hawaii Revised Statute (HRS) 329.38-5
- Act 151/House Bill 1602 Effective 08-01-18. Requires the inclusion of a label warning of the risks of addiction and death on the packaging of any opioid drug dispensed by a health care professional or pharmacist.
- Act 153/Senate Bill 2646 Effective 07-01-18 Pertains to practitioner utilization requirements of the PDMP
- Act 190/House Bill 2385 Effective 07-01-18. Relating to scheduling actions of substituted cathinones, cumyl-4-cn-binaca and dronabinol
K9 Kahu is assigned as NED’s electronic storage device detection dog. K9 Kahu’s main duty is to help with criminal investigations by locating hidden electronic storage devices such as: cellular phones, electronic thumb drives, and memory cards.
Facebook: Kahu Lum Lee & ESD K9 Kahu
Instagram: k9_kahu